MiniMed Group, Inc. (MMED)

MiniMed Group Income Statement

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023
Revenue	2,715	2,469	2,245
Revenue Growth (YoY)	9.96%	9.98%	-
Cost of Revenue	1,187	1,032	937
Gross Profit	1,528	1,436	1,308
Selling, General & Admin	1,080	1,057	960
Research & Development	436	437	429
Other Operating Expenses	157	11	-12
Total Operating Expenses	1,673	1,505	1,377
Operating Income	-146	-69	-69
Total Non-Operating Income (Expense)	-1	-1	-7
Pretax Income	-147	-70	-76
Provision for Income Taxes	52	38	16
Net Income	-213	-112	-96
Minority Interest in Earnings	15	5	5
Net Income to Common	-213	-112	-96
Free Cash Flow	-53	-107	-173
Free Cash Flow Per Share	-0.21	-	-
Gross Margin	56.28%	58.16%	58.26%
Operating Margin	-5.38%	-2.79%	-3.07%
Profit Margin	-7.29%	-4.33%	-4.10%
FCF Margin	-1.95%	-4.33%	-7.71%
EBITDA	-3	60	46
EBITDA Margin	-0.11%	2.43%	2.05%
EBIT	-146	-69	-69
EBIT Margin	-5.38%	-2.79%	-3.07%
Effective Tax Rate	-35.37%	-54.29%	-21.05%

Updated Apr 25, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q